FLUDEOXYGLUCOSE BIONT 200-2200 MBQ/ml 200-1300mbq/ml solution for injection
Active substance: fludeoxyglucose (18F)
V09IX04 Various | Tumour detection | Other diagnostic radiopharmaceuticals for tumour detection
Indicated for: diagnostic imaging
Find medicines for human use by name or active substance.
Browse by initial
521–540 of 836 medicines
Active substance: fludeoxyglucose (18F)
V09IX04 Various | Tumour detection | Other diagnostic radiopharmaceuticals for tumour detection
Indicated for: diagnostic imaging
Active substance: indapamide + amlodipine
C08GA02 Cardiovascular system | Calcium channel blockers | Calcium channel blockers and diuretics
Indicated for: hypertension
Active substance: indapamide + amlodipine
C08GA02 Cardiovascular system | Calcium channel blockers | Calcium channel blockers and diuretics
Indicated for: hypertension
Active substance: live attenuated flu vaccine
J07BB03 Antiinfectives for systemic use | Viral vaccines | Influenza vaccines
Indicated for: prevention of influenza
Active substance: live attenuated flu vaccine
J07BB03 Antiinfectives for systemic use | Viral vaccines | Influenza vaccines
Indicated for: prevention of influenza
Active substance: povidone
S01XA20 Sensory organs | Other ophthalmologicals
Indicated for: pharmaceutical excipient
Active substance: carbocisteine
R05CB03 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: carbocisteine
R05CB03 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: carbocisteine
R05CB03 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: respiratory disorders with viscous secretions
Active substance: acetylcysteine
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: viscous bronchial secretions; paracetamol overdose
Active substance: acetylcysteine
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: viscous bronchial secretions; paracetamol overdose
Active substance: acetylcysteine
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: viscous bronchial secretions; paracetamol overdose
Active substance: acetylcysteine
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: viscous bronchial secretions; paracetamol overdose
Active substance: acetylcysteine
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: viscous bronchial secretions; paracetamol overdose
Active substance: acetylcysteine
R05CB01 Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: viscous bronchial secretions; paracetamol overdose
Active substance: flumazenil
V03AB25 Various | All other therapeutic products | All other therapeutic products | Antidotes
Indicated for: reversal of benzodiazepine effects
Active substance: flumazenil
V03AB25 Various | All other therapeutic products | All other therapeutic products | Antidotes
Indicated for: reversal of benzodiazepine effects
Active substance: flumazenil
V03AB25 Various | All other therapeutic products | All other therapeutic products | Antidotes
Indicated for: reversal of benzodiazepine effects
Active substance: flumazenil
V03AB25 Various | All other therapeutic products | All other therapeutic products | Antidotes
Indicated for: reversal of benzodiazepine effects
Active substance: fluorometholone + tetrahydrozoline
S01BB03 Sensory organs | Antiinflammatory agents | Corticosteroids and mydriatics in combination
Indicated for: ocular inflammation
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.